Real-time enrollment status for this differentiated thyroid cancer clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 6:21 PM UTC
| NCT Number | NCT06458036 |
| Recruiting Status | Recruiting |
| Condition | Differentiated Thyroid Cancer |
| Phase | PHASE2 |
| Target Enrollment | 13 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Children's Hospital of Philadelphia |
| Last Updated on CT.gov | July 24, 2026 (Jul 24, 2026) |
As of August 27, 2026: Clinical trial NCT06458036 is currently recruiting participants. This phase2 study for differentiated thyroid cancer is actively seeking new participants at 5 locations across the United States. The study is sponsored by Children's Hospital of Philadelphia. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06458036 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06458036 was last updated Jul 24, 2026 (July 24, 2026). HelloStudys verifies this status automatically.